Amritsar: A research scholar from the department of pharmaceutical sciences at Guru Nanak Dev University (GNDU) represented India at the 26th Tetrahedron Symposium 2026 held in Shenzhen, China, according to a university release issued on Monday.Karanvir Singh, pursuing his PhD under the supervision of Prof Preet Mohinder Singh Bedi, participated in the symposium organised by Elsevier, which brought together scientists, researchers, and academicians from across the world to discuss recent advances in medicinal chemistry and allied sciences.During the symposium, Karanvir presented a scientific poster entitled ‘Design, Synthesis, and Biological Evaluation of Triazole-Linked Lignan-Monoterpenoid-Based Hybrid Molecules as Xanthine Oxidase Inhibitors with Potent In Vivo Efficacy’, said the release, adding that the research attracted considerable interest from international delegates and highlighted ongoing efforts toward the development of novel therapeutic agents for the management of hyperuricemia and related disorders.Uric acid is the final product of purine metabolism in humans, and elevated uric acid levels, a condition known as hyperuricemia, have emerged as a significant global health concern, said the release.
